Friday, August 17, 2018 11:15:54 PM
Beyond that, no-one really talks about it yet, but we have to prove clinical equivalence to a predicate device, and there's really a lot of stuff up in the air about that.
Is the predicate device single PORT and urogical indications only as per the SP of intuitive? Or is the predicate device as per multi-port and all the abdominal procedures? The FDA first and foremost wants clinical equivalence, but no-one knows anything as of yet, and what the FDA wants exactly, and what it will mean in terms of human trials required. If we do get FDA approval, I would not be surprised it will be initially for one indication only. But I'm no expert here, just going by my gut here and reading between the lines of the M&A, and anyone please show me wrong.
It's still a long road ahead till we get into the big money. But, first things first. I'm sure we'll have a nice cushion with a PPS over 10 in the next 12 months to be able to take the next blow. I can't imagine not getting the 3.20 warrants soon. Seriously, we're talking 0.10-0.11 cents here.
Have a good weekend.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM